MLH1 and Lynch syndrome: On the other hand, germline MMR genetic testing was not done in patients with MMR deficiency to confirm Lynch syndrome; for MLH1-deficient cases, we ruled out CIMP-associated tumors by analyzing the V600E BRAF mutation and MLH1 methylation status.